Global Mometasone Furoate Market, by Dosage Form (Nasal Spray, Cream, Ointment, Inhalers, Others), by Indication (Inflammatory Skin Disorders, Asthma, Allergic Rhinitis, Others), by Route Of Administration (Nasal Administration, Topical, Oral) , by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, And Africa), is estimated to be valued at US$ 1,182.9 million in 2022, and is expected to exhibit a CAGR of 7.4% during the forecast period (2022-2030).
Increasing number of awareness campaigns for asthma by non-profit organizations is expected to drive growth of the global mometasone furoate market over the forecast period as mometasone furoate is effective in treating the asthma. For instance, the Centers for Disease Controls and Prevention organized an awareness campaign on World Asthma Day, May 3 2022, in order to raise awareness about asthma and enhance the lives of all asthma sufferers. In the campaign individuals suffering from asthma and organizations dedicated to asthma control united with each other.
Moreover, rising number research and development activities related to mometasone furoate are expected to propel growth of the global mometasone furoate market during the forecast period. For instance, according to an article published in Journal of Personalized Medicine, an international, open access journal on personalized medicine, a study was performed in order to evaluate the efficacy of intranasal mometasone furoate in patients with non-allergic rhinitis (NAR) in Italy. The therapeutic response showed improvement in olfactory function. The results confirmed that intranasal mometasone furoate is an effective treatment for patients with NAR.
Global Mometasone Furoate Market- Impact of Coronavirus (COVID – 19) Pandemic
The COVID-19 pandemic has affected several markets across the globe and is also expected to hamper the global mometasone furoate market growth. The COVID-19 pandemic has affected demand and supply of healthcare products in three main ways; by directly affecting the production and demand; by creating disruptions in distribution channels; and due to its financial impact on firms and financial markets. However, Coronavirus (COVID-19) pandemic is expected to positively impact growth of the global mometasone furoate market during the forecast period. For instance, according to Philippines Covid-19 Living Clinical Practice Guidelines, November 2021, inhaled corticosteroids like mometasone furoate are effective in the treatment of Covid-19 with mild to moderate symptoms. Apart from anti-inflammatory effects mometasone furoate have anti-viral effects and are helpful in suppression the replication of SARS‐CoV‐2 and MERS‐CoV.
Browse 35 Market Data Tables and 33 Figures spread through 193 Pages and in-depth TOC on Global Mometasone Furoate Market, by Dosage Form (Nasal Spray, Cream, Ointment, Inhalers, Others), by Indication (Inflammatory Skin Disorders, Asthma, Allergic Rhinitis, Others), by Route Of Administration (Nasal Administration, Topical, Oral) , by Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, And Africa)
To know the latest trends and insights prevalent in the Global Mometasone Furoate Market, click the link below:
https://www.coherentmarketinsights.com/market-insight/mometasone-furoate-market-5198
Key Takeaways of the Global Mometasone Furoate Market:
- Global Mometasone Furoate market is expected to exhibit a CAGR of 7.4% over the forecast period (2022-2030). North America is expected to account for major market share over the forecast period (2022-2030), owing to increasing prevalence of inflammatory skin disorders and higher focus on advancing research related to mometasone furote. For instance, according to American Acadamy of dermatology, Atopic dermatitis, a type of inflammatory skin disorder affects up to 25 % of children and 2 to 3 % of adults every year.
- Some of the major players operating in the global mometasone furoate market include Cipla, Teva Pharmaceuticals, Glenmark Pharmaceuticals, AdvaCare Pharma, Medlab Pharmaceuticals Private Limited, Dermocare Laboratories, Iva Healthcare Private Limited, Unilab Chemicals & Pharmaceuticals Pvt Ltd., Organon group of companies, Cosette Pharmaceuticals, Taro Pharmaceutical Industries Ltd., and Hikma Pharmaceuticals
